We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
IntegraGen Announces Additional Financing
News

IntegraGen Announces Additional Financing

IntegraGen Announces Additional Financing
News

IntegraGen Announces Additional Financing

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "IntegraGen Announces Additional Financing"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The amount raised reinforces investors' confidence in IntegraGen's efforts to develop and market advances in molecular diagnostics and the company's financial performance in the field of genomic services. Building upon an existing strong cash position, these funds will sustain the development of genetic tests in colorectal and liver cancer as well as speed up R&D and commercialization efforts in the field of autism molecular diagnostics.

Bernard Courtieu, Chief Executive Officer of IntegraGen stated "We are extremely satisfied with this capital infusion which was achieved during extremely difficult market conditions. This is a testimonial to investors' confidence in IntegraGen's efforts, specifically those associated with the commercialization of a genetic autism screening test this year in the USA, as well as our progress in the field of oncology biomarkers. Based on our very strong cash position, we will be able to pursue our development efforts with even greater confidence."

Advertisement